AMAM
Ambrx Biopharma Inc
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
14 hedge funds and large institutions have $70.6M invested in Ambrx Biopharma Inc in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.79M | |
| 2 | +$427K | |
| 3 | +$44.4K | |
| 4 |
Millennium Management
New York
|
+$24.7K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$456 |
Top Sellers
| 1 | -$773K | |
| 2 | -$122K | |
| 3 | -$118K | |
| 4 |
BlackRock
New York
|
-$74.2K |
| 5 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
-$1K |